首页|肺移植围手术期体外膜肺氧合的应用研究

肺移植围手术期体外膜肺氧合的应用研究

扫码查看
目的 探讨将体外膜肺氧合(ECMO)应用于肺移植围手术期的应用效果。方法 选取2017年1月-2022年12月郑州大学第一附属医院收治的63例行肺移植的受者,回顾性分析患者临床资料,将63例患者依据ECMO置管方式分为静脉-静脉(venous-venous,V-V)组(23例)与静脉-动脉(venous-artery,V-A)组(40例),依据术后ECMO支持时间分为延长组(术后ECMO支持时间>72 h,7例)与未延长组(术后ECMO支持时间≤72 h,37例),对比V-A组与V-V组基础资料及术后临床转归情况,并比较延长组与未延长组预后情况。结果 V-A组与V-V组性别、年龄、肺移植方式、围术期ECMO支持时间、撤除情况及原发病比较,差异无统计学意义(P>0。05);V-A组与V-V组手术时间、再次插管率、探查止血率、ICU停留时间及住院时间比较,差异无统计学意义(P>0。05);V-A气管拔管时间长于V-V组,差异有统计学意义(P<0。05);延长组患者术后30 d、60 d、90 d累积生存率分别为85。71%、71。43%、57。14%,未延长组分别为91。89%、86。49%、78。38%,高于延长组,差异有统计学意义(P<0。05)。结论 肺移植受者围手术期应用ECMO具有重要作用,可提高患者生存率,V-V置管方式创伤小,相较于V-A置管可缩短气管拔管时间;术后ECMO支持时间延长相较于不延长患者预后更差。
Extracorporeal membrane oxygenation for lung transplantation of perioperative application
Objective To investigate the effect of extracorporeal membrane oxygenation(ECMO)in the perioperative period of lung transplantation.Methods A retrospective analysis was performed on 63 patients who received lung trans-plantation in the First Affiliated Hospital of Zhengzhou University from January 2017 to December 2022.According to different ECMO catheterization methods,the patients were divided into two groups,including 23 cases in group V-V and 40 cases in group V-A.According to the postoperative ECMO support time,the patients were divided into extend-ed group(ECMO support time>72 h,7 cases)and non-extended group(ECMO support time≤72h,37 cases).The basic data and postoperative clinical outcomes of the V-A group and the V-V group were compared,and the prog-nosis of the prolonged group and the non-prolonged group was compared.Results There was no significant difference between V-A group and V-V group in gender,age,lung transplantation mode,perioperative ECMO support time,re-moval situation and primary disease(P>0.05).There was no significant difference in operation time,reintubation rate,exploration hemostasis rate,ICU stay time and hospital stay between the V-A group and the V-V group(P>0.05).The duration of tracheal extubation in V-A group was longer than that in V-V group(P<0.05).The cumulative survival rates at 30 d,60 d and 90 d in the extended group were 85.71%,71.43% and 57.14%,respec-tively,while those in the non-extended group were 91.89%,86.49% and 78.38%,respectively,which were higher than those in the extended group(P<0.05).Conclusion The use of ECMO in the perioperative period of lung trans-plant recipients has an important role in improving the survival rate of patients.V-V catheterization has less trauma and can shorten the time of tracheal extubation compared with V-A catheterization.Patients with prolonged ECMO support had worse prognosis than those without prolonged ECMO support.

Extracorporeal membrane oxygenationLung transplantationApplyEffect

黄俊诚、黄无敌、朱雅欣、杨蒙蒙

展开 >

郑州大学第一附属医院外科ICU,郑州 450000

体外膜肺氧合 肺移植手术 应用 效果

2024

医药论坛杂志
中华预防医学会,河南省医学情报研究所

医药论坛杂志

影响因子:0.47
ISSN:1672-3422
年,卷(期):2024.45(19)